Xcout Intel
Vianautis Bio competitors & alternatives
The 12 closest competitors and alternatives to Vianautis Bio among healthcare & life sciences companies — ranked by similarity to what Vianautis Bio actually does, not by market-cap band.
Subscribe to see Vianautis Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Vianautis Bio
ViaNautis Bio Ltd. is a groundbreaking nanomedicine company headquartered in Cambridge, UK, at the forefront of genetic therapies. The company leverages its proprietary polyNaut platform to develop novel products for delivering genetic medicines.
Vianautis Bio at a glance
Vianautis Bio is a healthcare & life sciences company headquartered in United Kingdom. Its most recent funding round, Series A, raised $25M in November 2023. Xcout tracks 11 named people at Vianautis Bio, including Dr Adi Hoess (Chief Executive Officer).
Vianautis Bio leadership
- Dr Adi HoessChief Executive Officer
- Sam SmartChief Financial Officer
- Dr Denis CecchinChief Technical Officer
- Dr Ray JuppChief Scientific Officer
- Dr Samuel BarkerChief Business Officer
- Steven AltschulerChairman
5 more named people on record for Vianautis Bio, with roles, board committees and tenure — see the full roster →
Vianautis Bio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $25M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Vianautis Bio competitors
Ranked by semantic similarity — how close each company is to Vianautis Bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
NanoVation Therapeutics is a platform developer headquartered in Vancouver, British Columbia, that partners with leading pharmaceutical and biotech companies to enable genetic medicines.
Biotechnology
Houdini Bio is a biotechnology company headquartered in London, United Kingdom, with operations in Cambridge. The firm focuses on genetic medicine to unlock its full therapeutic potential and advance curative treatments.
Biotechnology
Averna Therapeutics is a biotechnology company developing genomic medicines utilizing RNA and lipid nanoparticle technologies. The company focuses on safe and efficient gene insertion and the treatment of rare genetic diseases through research and development teams located in Boston and Israel.
Biotech
Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. Additionally, Voyager is pursuing a Tau program aimed at various tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, alongside initiatives for spinal muscular atrophy. To advance its gene therapy product pipeline, the company has forged strategic collaboration and licensing agreements with key industry players such as Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. These partnerships cover the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and maintains its corporate headquarters in Cambridge, Massachusetts.
Biotech
Genevant Sciences is a biotechnology company headquartered in Vancouver, British Columbia, that develops world-class delivery platforms including lipid nanoparticles.
Biotechnology
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Biotechnology
DNA Nanobots, LLC is a biotechnology company founded in Columbus, Ohio, that develops products for targeted therapeutics and functionalized gene delivery.
Biotech
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Biotech
CPTx is a genetic medicines company that develops in vivo CAR-T therapies for cancer treatment. The company utilizes a proprietary single-stranded DNA (ssDNA) platform combined with lipid nanoparticle delivery systems to create scalable, non-viral genetic therapies.
Biotechnology
Eyevensys is a biotechnology company developing non-viral gene therapies for ophthalmic diseases. Its platform uses electro-transfection of the eye’s ciliary muscle to enable sustained local production of therapeutic proteins for retinal and other ocular conditions.
Biotechnology
Gemma Labs Inc. (GEMMABio) is a biotechnology company that develops gene therapies for rare diseases using next-generation AAV technology. The company focuses on programs targeting motor neuron disorders, skeletal conditions, and cardiomyopathies to serve the rare disease community.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Vianautis Bio and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Vianautis Bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →